Results 201 to 210 of about 742,291 (311)

Semen quality in acute leukemia patients: a retrospective study. [PDF]

open access: yesAnn Hematol
Buonacquisto A   +17 more
europepmc   +1 more source

Spatiotemporally Controlled Tumor Photodynamic/Immunotherapy Therapy Based on Upconversion Hybrid Nanosystem

open access: yesAdvanced Science, EarlyView.
PURH is constructed by a five‐layer upconversion nanoparticle (UCNP) surface coated with mesoporous silica, which encapsulates rose bengal (RB) within the mesoporous channels. Additionally, CpG oligonucleotides (CpG ODN) is linked to the surface, followed by the surface functionalization of hyaluronic acid (HA). This spatiotemporally controllable smart
Fang Wang   +9 more
wiley   +1 more source

The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia. [PDF]

open access: yesNat Commun
Ahlgren L   +28 more
europepmc   +1 more source

Targeting DESI2 as a Novel Therapeutic Strategy for JAK2‐Mutant Leukemias

open access: yesAdvanced Science, EarlyView.
Mass spectrometry‐based proteomics identify DESI2 as a novel component of the JAK2‐V617F complex, which associates with and stabilizes mutant JAK2 through deSUMOylation and deubiquitination, therefore promoting JAK2 mutant cell growth and MPN disease onset in vivo.
Husheng Mei   +32 more
wiley   +1 more source

Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults [PDF]

open access: bronze, 2001
Martyn T. Smith   +8 more
openalex   +1 more source

Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy

open access: yesAdvanced Science, EarlyView.
Lactate, once deemed a metabolic waste, emerges as a central regulator of cancer progression. This review elucidates how lactate and its epigenetic derivative, protein lactylation, orchestrate tumor metabolism, immune suppression, and therapeutic resistance.
Jiajing Gong   +5 more
wiley   +1 more source

Rare germline ETV6 variant associated with thrombocytopenia and acute leukemia. [PDF]

open access: yesAnn Hematol
Rajendra Kurup A   +4 more
europepmc   +1 more source

Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3 [PDF]

open access: bronze, 2004
Purva Bali   +12 more
openalex   +1 more source

Home - About - Disclaimer - Privacy